Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

2.1K

Pilot study results for a novel behavior plus nutrition intervention for caregivers of young children with type 1

Susana R Patton1, Cathleen Odar2, L Kurt Midyett3

  • 1Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS.

Journal of Nutrition Education and Behavior
|January 21, 2014
PubMed

Insights

A parent-based intervention improved glycemic control and mealtime behaviors in young children with type 1 diabetes mellitus (T1DM). The program showed promising results for managing T1DM in children.

Area of Science:

  • Pediatric Endocrinology
  • Behavioral Science
  • Nutritional Science

Background:

  • Type 1 diabetes mellitus (T1DM) in young children presents unique challenges for families, particularly concerning mealtime behaviors and nutrition.
  • Effective management requires interventions that address both behavioral and nutritional aspects.

Purpose of the Study:

  • To evaluate a parent-based educational intervention focused on improving mealtime behaviors and nutrition in families of young children with T1DM.
  • To assess the intervention's impact on glycemic control and behavioral outcomes.

Main Methods:

  • A 6-session intervention was delivered to 9 caregivers of children (mean age 5.0 years) with T1DM.
  • Assessments included dietary intake, acceptability of diet changes, mealtime behavior, and mean blood glucose levels before and after the intervention.

Main Results:

  • Mean daily blood glucose levels significantly decreased from 185 ± 46 mg/dL to 159 ± 40 mg/dL (P < .001).
  • Problematic parent and child mealtime behaviors were reduced.
  • No significant changes were detected in children's dietary intake indicators.

Conclusions:

  • The targeted behavior and nutrition intervention shows promise for enhancing glycemic control and behavior in young children with T1DM.
  • Further research, including larger randomized controlled trials, is needed to confirm these findings and assess long-term sustainability.
  • The program's techniques may be applicable to clinical practice for managing T1DM in pediatric populations.
Abstract

Keywords:
behaviorchilddiabetesglycemic controlnutritionpreschool

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28